Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
164.2 USD | +1.05% | -2.83% | +5.99% |
Apr. 17 | OSE: licensing agreement with AbbVie enters into force | CF |
Apr. 17 | OSE Immunotherapeutics Finalizes Drug License, Collaboration Deal With AbbVie | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.99% | 288B | |
+28.79% | 673B | |
+24.81% | 551B | |
-7.64% | 348B | |
+15.00% | 317B | |
+2.47% | 210B | |
-0.02% | 204B | |
-9.98% | 195B | |
-11.71% | 145B | |
-8.32% | 142B |
- Stock Market
- Equities
- ABBV Stock
- News AbbVie Inc.
- AbbVie's Skyrizi Secures European Union's Approval for Psoriatic Arthritis